Abbott Laboratories (NYSE:ABT)

59.19
Delayed Data
As of Apr 20
 -0.69 / -1.15%
Today’s Change
42.88
Today|||52-Week Range
64.60
+3.71%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line2.3B4.4B1.4B477.0M
 
 
 
 
 
Depreciation1.5B1.5B1.4B3.0B
 
 
 
 
 
Total Other Cash Flow333.0M-2.8B2.0B1.3B
 
 
 
 
 
Funds From Operations4.2B3.1B4.7B4.8B
 
 
 
 
 
Extraordinary Items0.000.00-25.0M-1.2B
 
 
 
Funds From/For Other Operating Expenses490.0M156.0M1.5B-1.9B
 
 
 
 
 
Net Cash Flow - Operating Activities3.7B3.0B3.2B5.6B
 
 
 
 
 
 
InvestingIncrease In Investments-1.5B-4.9B-2.8B-210.0M
 
 
 
 
 
Decrease In Investments5.6B6.4B3.7B2.8B
 
 
 
 
 
Capital Expenditures-1.1B-1.1B-1.1B-1.1B
 
 
 
 
 
Fixed Asset Disposal--230.0M25.0M6.0B
 
 
 
 
Net Assets From Acquisitions -3.3B-235.0M-80.0M-17.2B
 
 
 
 
 
Other Investing - Sources75.0M52.0M42.0M35.0M
 
 
 
 
 
Net Cash Flow Investing-202.0M406.0M-248.0M-9.6B
 
 
 
 
 
 
FinancingShort Term Borrowings1.3B-1.3B-1.8B-1.0B
 
 
 
 
 
Long Term Borrowings0.002.5B14.9B6.7B
 
 
 
 
Long Term Debt Reduction-577.0M-57.0M-12.0M-8.7B
 
 
 
 
 
Net Proceeds Stock Sale429.0M314.0M248.0M350.0M
 
 
 
 
 
Common Preferred Redeemed-2.2B-2.2B-522.0M-827.0M
 
 
 
 
 
Common Dividends-1.3B-1.4B-1.5B-1.8B
 
 
 
 
 
Cash Dividends Paid - Total-1.3B-1.4B-1.5B-1.8B
 
 
 
 
 
Other Sources - Financing----------
Other Uses - Financing400.0M17.0M195.0M13.0M
 
 
 
 
 
Net Cash Flow - Financing-2.7B-2.2B11.1B-5.3B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-143.0M-198.0M-483.0M116.0M
 
 
 
 
 
 
Net Change In Cash731.0M1.1B14.1B-9.3B